Transformation of cells by Rous sarcoma virus is dependent on the expression of virus encoded src gene. Experiments using microinjection or co-expression of dominant negative ras or raf genes has suggested that the mechanism by which v-src transforms cells involves ras and raf mediated signal transduction. But these conditions not only suppress v-src induced cell transformation, they also suppress normal cell proliferation. An alternative view is that v-src functions through its interaction with molecules involved in cell adhesion and determination of cell shape. The difficulty with this view is that there is little functional data to support it and the potential mechanisms by which cell adhesion may alter cell gene expression and cell proliferation are at a very early stage of development. The objective of this proposal is to fill this void and test the hypothesis that v-src operates by interfering with normal cell signaling pathways which are linked to cell adhesion and particularly to integrin family receptors. To test this proposition, we will reexamine two old model systems for cell transformation from the perspective of a possible link between v-src dependent cell proliferation and v-src mediated modulation of integrin mediated cell adhesion. (i) Deprivation of serum causes cells to arrest in Go. Activation of v-src in the arrested cells induces cell proliferation. The role of integrins in the establishment of the quiescent state and the potential requirement for integrin modulation to reinitiate cell proliferation will be tested. Does v-src induced proliferation depend on its effect to weaken integrin extracellular matrix links? (ii) Transformed fibroblasts are able to proliferate in suspension whereas normal fibroblasts require an adhesive substrate. The role of integrins in supplying this adhesion signal and the possibility that v-src disrupts this signal will be examined using cell cycle analysis, functional analysis of adhesion requirements and genetic manipulation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA049866-08
Application #
2414186
Study Section
Experimental Virology Study Section (EVR)
Project Start
1989-05-01
Project End
2000-04-30
Budget Start
1997-05-01
Budget End
1998-04-30
Support Year
8
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Garcia, Andres J; Schwarzbauer, Jean E; Boettiger, David (2002) Distinct activation states of alpha5beta1 integrin show differential binding to RGD and synergy domains of fibronectin. Biochemistry 41:9063-9
Boettiger, D; Huber, F; Lynch, L et al. (2001) Activation of alpha(v)beta3-vitronectin binding is a multistage process in which increases in bond strength are dependent on Y747 and Y759 in the cytoplasmic domain of beta3. Mol Biol Cell 12:1227-37
Garcia, A J; Boettiger, D (1999) Integrin-fibronectin interactions at the cell-material interface: initial integrin binding and signaling. Biomaterials 20:2427-33
Garcia, A J; Vega, M D; Boettiger, D (1999) Modulation of cell proliferation and differentiation through substrate-dependent changes in fibronectin conformation. Mol Biol Cell 10:785-98
Garcia, A J; Huber, F; Boettiger, D (1998) Force required to break alpha5beta1 integrin-fibronectin bonds in intact adherent cells is sensitive to integrin activation state. J Biol Chem 273:10988-93
Shih, D T; Boettiger, D; Buck, C A (1997) Epitopes of adhesion-perturbing monoclonal antibodies map within a predicted alpha-helical domain of the integrin beta 1 subunit. J Cell Sci 110 ( Pt 20):2619-28
Boettiger, D; Enomoto-Iwamoto, M; Yoon, H Y et al. (1995) Regulation of integrin alpha 5 beta 1 affinity during myogenic differentiation. Dev Biol 169:261-72
Yoon, H; Boettiger, D (1994) Expression of v-src alters the expression of myogenic regulatory factor genes. Oncogene 9:801-7
Enomoto, M; Leboy, P S; Menko, A S et al. (1993) Beta 1 integrins mediate chondrocyte interaction with type I collagen, type II collagen, and fibronectin. Exp Cell Res 205:276-85
Enomoto, M I; Boettiger, D; Menko, A S (1993) Alpha 5 integrin is a critical component of adhesion plaques in myogenesis. Dev Biol 155:180-97

Showing the most recent 10 out of 14 publications